Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Get With The Guidelines-Heart Failure Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02693509
Recruitment Status : Recruiting
First Posted : February 26, 2016
Last Update Posted : June 27, 2019
Sponsor:
Information provided by (Responsible Party):
American Heart Association

Brief Summary:
Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Condition or disease Intervention/treatment
Heart Failure Other: GWTG Heart Failure program

Detailed Description:

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.

Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings.

Achievement measures tracked through Get With The Guidelines-Heart Failure:

  • Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge
  • Evidence-based specific beta blockers
  • Measure left ventricular function
  • Post-discharge appointment for heart failure patients

Quality Measures tracked through Get With The Guidelines-Heart Failure:

  • Aldosterone antagonist at discharge
  • Anticoagulation for atrial fibrillation
  • Hydralazine nitrate at discharge
  • DVT prophylaxis
  • CRT-D or CRT-P placed or prescribed at discharge
  • ICD counseling, or ICD placed or prescribed at discharge
  • Influenza vaccination during flu season
  • Pneumococcal vaccination
  • Follow-up visit within 7 days or less

Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloadable/ucm_310967.pdf

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 128026 participants
Observational Model: Cohort
Time Perspective: Other
Target Follow-Up Duration: 1 Year
Official Title: Get With The Guidelines-Heart Failure Registry
Study Start Date : January 2005
Estimated Primary Completion Date : January 2040
Estimated Study Completion Date : January 2040

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure


Intervention Details:
  • Other: GWTG Heart Failure program
    Evidence based guideline recommended therapies and counseling prior to hospital discharge


Primary Outcome Measures :
  1. 30 day readmission rate [ Time Frame: 30 days post discharge from hospital ]
    Percent of index encounters where there is a readmission within 30 days

  2. 60 day readmission rate [ Time Frame: 60 days post discharge from hospital ]
    Percent of index encounters where there is a readmission within 60 days

  3. 90 day readmission rate [ Time Frame: 90 days post discharge from hospital ]
    Percent of index encounters where there is a readmission within 90 days



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 125 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
The study populations is primary diagnosis or secondary diagnosis of heart failure
Criteria

Inclusion Criteria:

  • Patients hospitalized with congestive heart failure.

Exclusion Criteria:

  • Patients who do not have congestive heart failure,
  • Patients under age of 18,
  • Patients not admitted as inpatients.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02693509


Contacts
Layout table for location contacts
Contact: Melanie Shahriary, RN, BSN 301-651-7548 melanie.shahriary@heart.org
Contact: Christine Rutan Christine.Rutan@heart.org

Locations
Layout table for location information
United States, Texas
American Heart Association Recruiting
Dallas, Texas, United States, 75231
Contact: Melanie Shahriary, BSN    301-651-7548    melanie.shahriary@heart.org   
Contact: Christine Rutan       christine.rutan@heart.org   
Sponsors and Collaborators
American Heart Association
Investigators
Layout table for investigator information
Principal Investigator: Javed Butler, MD American Heart Association
Study Director: Gayle Whitman, PHD, RN American Heart Association
Additional Information:

Publications:
American Academy of Family Physicians; American Academy of Hospice and Palliative Medicine; American Nurses Association; American Society of Health-System Pharmacists; Heart Rhythm Society; Society of Hospital Medicine, Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Piña IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB; ACCF/AHA Task Force on Performance Measures, Peterson ED, Masoudi FA, DeLong E, Erwin JP 3rd, Fonarow GC, Goff DC Jr, Grady KL, Green LA, Heidenreich PA, Jenkins KJ, Loth A, Shahian DM. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. J Am Coll Cardiol. 2012 May 15;59(20):1812-32. doi: 10.1016/j.jacc.2012.03.013. Epub 2012 Apr 23.

Layout table for additonal information
Responsible Party: American Heart Association
ClinicalTrials.gov Identifier: NCT02693509    
Other Study ID Numbers: GWTG01
First Posted: February 26, 2016    Key Record Dates
Last Update Posted: June 27, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases